James Hung, 2004 FDA/Industry Management of Missing Data in Clinical Trials from a Regulatory Perspective H.M. James Hung Div. of Biometrics I, OB/OPaSS/CDER/FDA.
Random vs. systematic sampling J. Gallego, MARS AGRI4CAST.
Structural Equation Models An Overview
Schmidt & Hunter Approach to r Bare Bones. Statistical Artifacts Extraneous factors that influence observed effect Sampling error* Reliability Range restriction.
